Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
FRA:YMP3
Delisted

Symphony Holdings Limited Stock Price (Quote)

Frankfurt Stock Exchange
Open Broker Account
0.0890€
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days 0.0890€ 0.0890€ Wednesday, 17th Aug 2022 YMP3.F stock ended at 0.0890€. During the day the stock fluctuated 0% from a day low at 0.0890€ to a day high of 0.0890€.
90 days 0.0890€ 0.0890€
52 weeks 0.0890€ 0.0905€

Historical Symphony Holdings Limited prices

Date Open High Low Close Volume
Dec 03, 2019 0.101€ 0.101€ 0.101€ 0.101€ 22 500
Dec 02, 2019 0.102€ 0.102€ 0.102€ 0.102€ 22 500
Nov 29, 2019 0.101€ 0.101€ 0.101€ 0.101€ 22 500
Nov 28, 2019 0.102€ 0.102€ 0.102€ 0.102€ 22 500
Nov 27, 2019 0.102€ 0.102€ 0.102€ 0.102€ 22 500
Nov 26, 2019 0.102€ 0.102€ 0.102€ 0.102€ 22 500
Nov 25, 2019 0.102€ 0.102€ 0.102€ 0.102€ 22 500
Nov 22, 2019 0.103€ 0.103€ 0.103€ 0.103€ 22 500
Nov 21, 2019 0.101€ 0.101€ 0.101€ 0.101€ 22 500
Nov 20, 2019 0.103€ 0.103€ 0.103€ 0.103€ 22 500
Nov 18, 2019 0.102€ 0.102€ 0.101€ 0.101€ 22 500
Nov 15, 2019 0.101€ 0.101€ 0.101€ 0.101€ 22 500
Nov 14, 2019 0.0995€ 0.0995€ 0.0995€ 0.0995€ 22 500
Nov 13, 2019 0.0985€ 0.0985€ 0.0985€ 0.0985€ 22 500
Nov 12, 2019 0.101€ 0.101€ 0.101€ 0.101€ 22 500
Nov 11, 2019 0.0980€ 0.0980€ 0.0980€ 0.0980€ 22 500
Nov 08, 2019 0.0990€ 0.0990€ 0.0990€ 0.0990€ 22 500
Nov 07, 2019 0.100€ 0.100€ 0.100€ 0.100€ 22 500
Nov 06, 2019 0.104€ 0.104€ 0.104€ 0.104€ 22 500
Nov 05, 2019 0.104€ 0.104€ 0.104€ 0.104€ 22 500
Nov 04, 2019 0.106€ 0.106€ 0.106€ 0.106€ 22 500
Nov 01, 2019 0.104€ 0.104€ 0.104€ 0.104€ 22 500
Oct 31, 2019 0.102€ 0.102€ 0.102€ 0.102€ 22 500
Oct 30, 2019 0.103€ 0.103€ 0.103€ 0.103€ 22 500
Oct 29, 2019 0.105€ 0.105€ 0.105€ 0.105€ 22 500
Click to get the best stock tips daily for free!

About Symphony Holdings Limited

Symphony Holdings Limited Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... YMP3.F Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT